Disease and Genetic Testing
Circulating Tumor DNA (ctDNA) Cancer Risk Assessment
The Circulating Tumor DNA (ctDNA) Cancer Risk Assessment can detect 270 cancer genes. The test conducts professional analysis based on the covered gene mutation data related to common cancers in Asia and Chinese, making the test results more accurate and consistent with the constitution of Asian regions and Chinese people. The new OEC detection technology can detect the entire gene, which is different from the traditional method that only detects hot-spots. It can cover more genetic mutations related to cancer development; it can also detect fusion genes common in cancer, which can provide patients with deeper and more comprehensive information.
Disease and Genetic Testing
HK$66,000





